Resources
- BNET Author Biography
Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years. He is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. He has also won the Neal award for business journalism, an S.P.J. award for investigative journalism, and the N.J. Press...- more about Jim Edwards »
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Laid-Off Merck Staff: Did You Get Your $112,000?
- It has cost Merck roughly $112,366 to lay off each of 4,310 executives since it announced a restructuring program late last year, according to an SEC filing. The restructuring was announced in October 2008, and Merck gave an update in its most recent 10-Q (see page 43). by Jim Edwards
- Blog posts 2009-11-06
- Snuggie Infomercial Retooled for Weezer CD Launch. It's Not a Joke.
- Rock band Weezer and the makers of the Snuggie sleeved blanket have retooled the infamous infomercial -- in which people feel "trapped" under ordinary blankets -- to sell a Weezer-branded Snuggie video below. Band members now appear in the Snuggie ad, snuggling under their hideous blankets on some of middle-America's...
- Blog posts 2009-11-06
- Pfizer Aiming for 30,900 Layoffs Through 2012
- Pfizer has laid off 26,300 employees since 2005, and hopes eventually to lay off a total of 30,900 through 2012, according to its 10-Q filing with the SEC. The company had several rounds of layoffs before its acquisition of Wyeth in an attempt to get $6 billion in annual savings...
- Blog posts 2009-11-06
- AstraZeneca's New Blog Is Slammed by Critics
- AstraZeneca AZN has launched a blog -- AZ Health Connections -- and the critics don't like it. There have only been five posts on it since Oct. 16, but already PharmExec has declared that the blog "falls flat" and Pharma Marketer says the posts "leave little upon which to engage."...
- Blog posts 2009-11-06
- Toyota and Saatchi Used Images From Flickr Without Permission
- Toyota TM and its ad agency, Saatchi & Saatchi, have been accused of stealing photos from Flickr for use on a web site for the Toyota 4Runner. Toyota has apologized. by Jim Edwards
- Blog posts 2009-11-06
- Chelsea F.C.'s Need for Stadium Sponsor Proves It Fumbled Samsung Deal
- Chelsea F.C. are seeking a sponsor for the club's stadium, Stamford Bridge. The price is between £100 million and £150 million for a period of 10 years. The move validates an argument BNET made in July: that Chelsea has drastically undervalued its current partnership with Samsung and is losing money...
- Blog posts 2009-11-06
- Weight-Loss Drugs -- Big Pharma’s Elusive El Dorado
- With America’s obesity problem getting worse by the day, there's plenty of money to be made fighting fat with new drugs. So why do weight-loss pills keep going down in flames? by Jim Edwards
- Blog posts 2008-07-30
- What’s Inside That FTC Report on Junk Food Marketing?
- The FTC detailed this week how much money is spent marketing junk food to kids. Most stories, like this one in the New York Times, went with the headline number: $1.6 billion. But the full report is more than 100 pages long, and filled with scary hidden...
- Blog posts 2008-07-31
- FDA Probes Shine Harsh Light on Pharma Biz
- It must be awful to work at the FDA right now. There you are, sitting in your cubicle, trying to make sure the pharmaceutical industry cures more people than it kills. But every five minutes some investigator from the Government Accountability Office calls you into the conference room for a...
- Blog posts 2008-07-31
- Should We Be Surprised That Schering-Plough Execs Are "Surprised" By Sugammadex Rejection?
- Yet another setback for Schering-Plough seems to have taken top management by surprise. Schering’s shares slid nearly four percent by midafternoon on the news that its sugammadex anesthesia-recovery drug would not be approved by the FDA. In a statement, Schering VP Thomas Koestler said he was “surprised...
- Blog posts 2008-08-01
- Johns Hopkins in Pharma Funding Flap
- Is Johns Hopkins University Medical School offering to endorse drug company "educational" materials for money? That was the allegation made last week by Daniel Carlat, a blogger and psychiatrist in private practice. Johns Hopkins, naturally, denies the claim. Carlat says Johns Hopkins is offering...
- Blog posts 2008-08-05
- GSK Roiled by Layoffs: 350 R&D Staff Cut; Scientists in Italy Stage a Strike
- Confusion continues at GlaxoSmithKline this morning as R&D employees attempt to figure out if they'll be receiving pink slips and their bosses attempt to keep everyone calm. Tension at the company has been building since Chemistry World reported that GSK sought hundreds of job cuts internationally at...
- Blog posts 2008-08-05
- Is Pfizer's Sleeping Pill Obsession Running up King Stock?
- Trading in options on King Pharmaceuticals shares reached a four-year frenzy yesterday, Reuters reported, and King shares rose to an 11-month high on rumors that Pfizer may be interested in acquiring it. Pfizer pfollowers know that CEO Jeff Kindler made a lot of noise a few years...
- Blog posts 2008-08-06
- As "Superbugs" Rise, Companies Abandon Antibiotic Research
- This week's must-read is Jerome Groopman's article on super-resistant bacteria in the New Yorker. If you get infected, the bacteria destroy your lungs and you end up drowning in your own blood. There's no cure: Antibiotics no longer work against them. These bugs are "literally resistant to...
- Blog posts 2008-08-07
- GSK and Others See Massachusetts Showdown Over Drug-Marketing Reform
- There are two ideas floating in the world of politics to curb the way drug companies give doctors gifts and often biased information. One of them is a good idea, and one of them is a bad idea. Drug companies -- such as GlaxoSmithKline -- have chosen...
- Blog posts 2008-08-08
- GSK's Alli Diet Drug Has Problems With Your "Fat Friend"
- The official blog of GlaxoSmithKline's Alli diet drug franchise has suddenly adopted a decidedly different voice. Alliconnect used to be a series of posts about health, nutrition, and some upfront warnings about Alli's side effects eat too much fatty food and you can lose bowel control. It...
- Blog posts 2008-08-11
- It’s Good News, Bad News for Gilead’s HIV Pill
- The good news: The FDA approved Viread, Gilead’s dwindling HIV treatment, as a therapy for hepatitis B. The drug’s sales had gone down to $613 million from a peak of $783 million as newer combination drugs -- including Gilead’s own Atripla, which includes Viread -- eroded the market for standalone...
- Blog posts 2008-08-12
- GSK Employees Really Love Their Boss's Book -- It's "Better Than Harvard"!
- Stephen Stefano, one of GlaxoSmithKline's senior executives in charge of commercial strategy, has written a book about leadership. It's called Passion and ICE. And, according to the employees and business partners of the senior-vice-president-of-managed-markets-and-neurohealth-divisions-turned-motivational speaker, Steve's book is totally awesome! Here's a selection of the completely unbiased,...
- Blog posts 2008-08-13
- At Sepracor, a Cost-Cutting Exercise Proves Expensive
- Last year, Sepracor, the maker of sleeping pill Lunesta, announced it would reduce its sales and marketing expenses by $90-100 million in 2008, "including an anticipated reduction of approximately 300 sales force positions." The company said it needed to make the layoffs because, by last October, its revenues were falling....
- Blog posts 2008-08-13
- Not Everyone Thinks Pharma's Legal Liabilities Are Impossible to Calculate
- Few things are less sexy than proposed changes in accounting rules for drug companies, but bear with me -- this is actually interesting. Lilly, Johnson & Johnson, Merck, Novartis, Pfizer and Wyeth have complained about a rule change that would require them to estimate how large their...
- Blog posts 2008-08-14
- << Previous
- page 1 of 78
- Next >>
Refining Tags
- Marketing (340 results)
- Finance (309 results)
- Advertisement (300 results)
- Human Resources (226 results)
- Advertising & Promotion (182 results)
- Business Operations (180 results)
- Government (164 results)
- Sales (162 results)
- Pfizer Inc. (154 results)
- Sales Strategy (150 results)
- Federal Government (134 results)
- Agency (131 results)
- Investment (127 results)
- Workforce Management (110 results)
- Operational Accounting (105 results)
- Sales Force Management (104 results)
- FDA (96 results)
- Layoff (84 results)
- Benefits (81 results)
- Financial Accounting (77 results)
- Revenue (76 results)
- Healthcare (72 results)
- Corporate Law (69 results)
- Internet (67 results)
- Litigation (63 results)
- Mergers & Acquisitions (58 results)
- Marketing Research (56 results)
- Corporate Communications (54 results)
- CEO (54 results)
- Vertical Industries (50 results)
- Management (49 results)
- Branding (48 results)
- Job (47 results)
- Bayer AG (46 results)
- Johnson & Johnson (46 results)
- Personal Finance (44 results)
- Merck & Co. Inc. (44 results)
- Recruitment & Selection (43 results)
- WPP (42 results)
- Corporate Governance (41 results)
- Software (40 results)
- AstraZeneca Plc. (38 results)
- Gender And Diversity (38 results)
- Wyeth (37 results)
- Financial Planning (37 results)
- Stock (37 results)
- Enterprise Software (36 results)
- Blogging (34 results)
- Pharmaceutical Company (34 results)
- Personal Technology (33 results)
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
